Despite recent claims that “free trade is dead,” fellow Simon Lester explains that America was never close to anything resembling free trade in the first place. Instead, current U.S. trade policy, just like past policy, reflects a messy mix of free market and industrial policy views.
Much about the mutiny by Russia's Wagner Group remains shrouded in mystery. But one thing is clear: Vladimir Putin's regime is more fragile than many thought, writes Bonner Means Baker Fellow Joe Barnes.
President Joe Biden recently announced that the U.S. will support efforts to train Ukrainian personnel in the use of F-16 fighter aircraft. What will this mean for the future of the conflict and the involvement of the United States? Fellow Joe Barnes explains.
The Russia-Ukraine war may have strengthened the NATO alliance. But it also raises critical questions about Europe’s security architecture and U.S. policy toward China.
It's been one year since Russia invaded Ukraine. Where do things stand now? Fellow Joe Barnes explores recent developments, including Biden's surprise trip to Kyiv this week, and why the prospect of a full Russian “victory” has long since vanished.
As Russia continues to target energy infrastructure, a dangerous winter could be on the horizon for millions of Ukrainians. Bonner Means Baker Fellow Joe Barnes examines the various factors at play and what’s ahead for the brutal war in Ukraine.
Drug companies that bypass distributors and offer generics directly to patients, like the Mark Cuban Cost Plus Drug Company, could disrupt the pharmaceutical supply chain and ultimately save thousands of lives.
Although a Republican House is not a disaster for Biden’s foreign policy, it could complicate his job as he pursues policies toward China and Ukraine, writes fellow Joe Barnes.